Found 101 clinical trials
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF) (GAP)
The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and
- 39 views
- 23 Jan, 2022
- 1 location
Dyspnea and Idiopathic Pulmonary Fibrosis (DYS-PID)
Longitudinal prospective exploratory study on the evolution of dyspnea, in its sensory and affective dimensions, in patients followed for idiopathic pulmonary fibrosis (IPF), between inclusion
- 0 views
- 19 Apr, 2022
- 1 location
Cohort of IPF Patients Experiencing an Exacerbation
Extension of the PFBIO cohort which includes patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) for longitudinal follow-up for up to 5 years. In the PFBIO-EXA extension
- 0 views
- 10 Nov, 2021
- 1 location
The Role of Laryngopharyngeal Reflux in IPF
(LPF) in idiopathic pulmonary fibrosis (IPF).
- 33 views
- 13 Oct, 2022
- 1 location
Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is characterized by a poor prognosis, with a progressive decline in lung function and a considerable variability in the disease's natural history. Besides
- 138 views
- 25 Nov, 2021
- 2 locations
Pulmonary Fibrosis Biomarker Cohort - a Prospective Cohort of Incident Patients With IPF (PFBIO)
Incident patients with idiopathic pulmonary fibrosis (IPF) in Denmark will be offered inclusion and followed up for up to 5 years with measurements of blood biomarkers and measurements of
- 81 views
- 24 Feb, 2022
- 1 location
Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay
Patients with newly diagnosed IPF are investigated for the diagnostic delay before a diagnosis of IPF is made.
- 67 views
- 23 Feb, 2022
- 2 locations
Prospective Observational Investigation of Possible Correlations Between Change in FVC and Change in Cough or Dyspnea Scores Using the Living With Pulmonary Fibrosis Questionnaire (L-PF) Between Baseline and After Approximately 52 Weeks of Nintedanib Treatment in Patients Suffering From Chronic Fibrosing ILD With a Progressive Phenotype (INREAL)
fibrosing interstitial lung disease (ILD) with a progressive phenotype (excluding idiopathic pulmonary fibrosis (IPF)).
- 0 views
- 17 Oct, 2022
- 14 locations
Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases (IRM-ILD)
most common ILD is idiopathic pulmonary fibrosis (IPF). Metabolomics provides a "snapshot" in time of all metabolites present in a biological sample. The imaging procedure should take approximately 20
- 44 views
- 06 May, 2022
- 1 location
Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease
We aim to clarify the relationship between sleep hygiene and the onset of sarcopenia or cognitive dysfunction using sleep time, arousal, and sleep quality as indicators in COPD or IPF patients
- 0 views
- 24 Mar, 2022
- 1 location